Arian Lundberg

JSON
CSV
XLSX
TXT

Primary: Shown in the list of current labels.

Year 2025

DOI Crossref
Early gonadotoxic effects of cyclophosphamide on the prepubertal testis and the feasibility of reducing toxicity through combined antioxidant therapy
Eskafinoghani A, Reyes Palomares A, Hao X, ..., Lundberg A, Rodriguez-Walberg KA
- - (-) - [2025-03-19; online 2025-03-19]
Arian Lundberg DDLS Fellow
PubMed DOI Crossref
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer.
Chesner LN, Polesso F, Graff JN, ..., Feng FY, Moran AE
Cancer Discov 15 (3) 481-494 [2025-03-03; online 2024-12-09]
Arian Lundberg DDLS Fellow

Year 2024

PubMed DOI Crossref
Elucidating acquired PARP inhibitor resistance in advanced prostate cancer.
Seed G, Beije N, Yuan W, ..., Carreira S, de Bono J
Cancer Cell 42 (12) 2113-2123.e4 [2024-12-09; online 2024-11-21]
Arian Lundberg DDLS Fellow
PubMed DOI Crossref
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer.
Calì B, Troiani M, Bressan S, ..., de Bono J, Alimonti A
Cancer Cell 42 (10) 1676-1692.e11 [2024-10-14; online 2024-09-19]
Arian Lundberg DDLS Fellow
PubMed DOI Crossref
BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity.
Westaby D, Jiménez-Vacas JM, Figueiredo I, ..., de Bono J, Sharp A
J. Clin. Invest. 134 (18) - [2024-09-17; online 2024-09-17]
Arian Lundberg DDLS Fellow
PubMed DOI Crossref
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression.
Shrestha R, Chesner LN, Zhang M, ..., Quigley DA, Feng FY
Cancer Res. 84 (18) 3086-3100 [2024-09-16; online 2024-07-11]
Arian Lundberg DDLS Fellow
PubMed DOI Crossref
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer.
Zhu X, Farsh T, Vis D, ..., van der Heijden MS, Feng FY
J. Clin. Invest. 134 (19) - [2024-08-13; online 2024-08-13]
Arian Lundberg DDLS Fellow
PubMed DOI Crossref
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer.
Zhao SG, Bootsma M, Zhou S, ..., Lupien M, Feng FY
Nat. Genet. 56 (8) 1689-1700 [2024-08-00; online 2024-07-17]
Arian Lundberg DDLS Fellow
PubMed DOI Crossref
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression.
Zhang M, Sjöström M, Cui X, ..., Feng FY, Quigley DA
Nat. Cell Biol. 26 (7) 1176-1186 [2024-07-00; online 2024-06-13]
Arian Lundberg DDLS Fellow

Year 2023

PubMed DOI Crossref
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.
Lundberg A, Zhang M, Aggarwal R, ..., Small EJ, Quigley DA
Cancer Res. 83 (16) 2763-2774 [2023-08-15; online 2023-06-08]
Arian Lundberg DDLS Fellow

Year 2022

PubMed DOI Crossref
Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer.
Feng E, Rydzewski NR, Zhang M, ..., Sjöström M, Zhao SG
Clin. Cancer Res. 28 (24) 5396-5404 [2022-12-15; online 2022-10-20]
Arian Lundberg DDLS Fellow
PubMed DOI Crossref
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.
Sjöström M, Zhao SG, Levy S, ..., Quigley DA, Feng FY
Cancer Res. 82 (21) 3888-3902 [2022-11-02; online 2022-10-18]
Arian Lundberg DDLS Fellow
PubMed DOI Crossref
Reclassifying tumour cell cycle activity in terms of its tissue of origin.
Lundberg A, Yi JJJ, Lindström LS, Tobin NP
NPJ Precis Oncol 6 (1) 59 [2022-08-20; online 2022-08-20]
Arian Lundberg DDLS Fellow
PubMed DOI Crossref
B cell-related gene signature and cancer immunotherapy response.
Lundberg A, Li B, Li R
Br. J. Cancer 126 (6) 899-906 [2022-04-00; online 2021-12-17]
Arian Lundberg DDLS Fellow

Year 2020

PubMed DOI Crossref
A pan-cancer analysis of the frequency of DNA alterations across cell cycle activity levels.
Lundberg A, Lindström LS, Parker JS, ..., Bergh J, Tobin NP
Oncogene 39 (32) 5430-5440 [2020-08-00; online 2020-06-24]
Arian Lundberg DDLS Fellow

Year 2019

PubMed DOI Crossref
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours.
Lundberg A, Lindström LS, Li J, ..., Bergh J, Tobin NP
Breast Cancer Res. 21 (1) 34 [2019-02-28; online 2019-02-28]
Arian Lundberg DDLS Fellow

Year 2017

PubMed DOI Crossref
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts.
Lundberg A, Lindström LS, Harrell JC, ..., Bergh J, Tobin NP
Clin. Cancer Res. 23 (24) 7512-7520 [2017-12-15; online 2017-09-29]
Arian Lundberg DDLS Fellow
PubMed DOI Crossref
PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients.
Tobin NP, Lundberg A, Lindström LS, ..., Hatschek T, TEX Trialists Group
Clin. Cancer Res. 23 (23) 7225-7231 [2017-12-01; online 2017-09-29]
Arian Lundberg DDLS Fellow
SciLifeLab Data Centre
Publications 9.5.1